HOME_PAGE_HEADER_CONTENT
Learn More-HP Updated
Learn More
Featured News
Press Releases
Wed Oct 30 00:00:00 GMT-05:00 2024
NEW
Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
Download
Tue Oct 01 00:00:00 GMT-05:00 2024
ENHERTU® Granted Priority Review in the U.S. for Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer Who Have Received at Least One Line of Endocrine Therapy
Download
Mon Sep 23 00:00:00 GMT-05:00 2024
Datopotamab Deruxtecan Final Overall Survival Results Reported in Patients with Metastatic HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Breast01 Phase 3 Trial
Download